2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: Selective Disinhibition of Thalamus by Globus Pallidus Internus: Failure of a Normal Control Mechanism in Childhood Dystonia

T. Sanger, E. Arguelles, M. Liker (Los Angeles, CA, USA)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: Self-reported substance abuse in a real-world sample of Tourette Syndrome and other tic disorder subjects

W. Deeb, A. Elkouzi, I. Malaty (Gainesville, FL, USA)

Tics/Tourette · Les Muses Terrace, Level 3

1:45pm-3:15pm: Sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy

L. Marques, V. Silva, J. Araújo, S. Varanda, G. Carneiro, M. Rodrigues (Braga, Portugal)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Serotonergic function in De Novo Parkinson’s Disease

HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)

Neurophysiology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Serum Inflammatory Profile for the Discrimination of tremor severity in essential tremor

Z. Muruzheva, D. Traktirov, I. Ivleva, V. Maystrenko, M. Karpenko (Saint-Petersburg, Russian Federation)

Tremor · Les Muses Terrace, Level 3

1:45pm-3:15pm: Serum mucosal chemokine levels in patients with Parkinson disease.

S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Serum non-mercaptalbumin as a potential biomarker in Parkinson’s disease and related disorders

S. Ueno, T. Hatano, A. Okuzumi, S. Saiki, Y. Oji, A. Mori, T. Koinuma, M. Fujimaki, H. Takeshige-Amano, K. Yasukawa, Y. Yatomi, H. Ikeda, N. Hattori (Tokyo, Japan)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study

C. Koros, AM. Simitsi, M. Stamelou, D. Papadimitriou, A. Bougea, I. Pachi, N. Papagiannakis, A. Prentakis, E. Angelopoulou, R. Antonellou, M. Bozi, X. Geronicola Trapali, L. Stefanis (Athens, Greece)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Serum uric acid levels and cognitive function in Parkinson’s disease

J. Difrancisco-Donoghue, W. Werner, B. Krishnamachari, K. Arabian, E. Thomas, D. Granger, R. Gallagher (Irvine, CA, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3